CBNK(CBNK)
CBNK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $269M | $296M |
| Low | $268M | $295M |
| High | $269M | $296M |
| EBITDA Avg | $69M | $75M |
| Low | $69M | $75M |
| High | $69M | $76M |
| EBIT Avg | $67M | $73M |
| Low | $67M | $73M |
| High | $67M | $73M |
| Net Income Avg | $57M | $63M |
| Low | $57M | $62M |
| High | $57M | $63M |
| EPS Avg | $3.43 | $3.79 |
| Low | $3.43 | $3.79 |
| High | $3.44 | $3.80 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $69M | $71M | $70M | $73M | $75M | $77M |
| Low | $69M | $71M | $70M | $73M | $75M | $77M |
| High | $69M | $71M | $70M | $73M | $76M | $77M |
| EBITDA Avg | $18M | $18M | $18M | $19M | $19M | $20M |
| Low | $18M | $18M | $18M | $19M | $19M | $20M |
| High | $18M | $18M | $18M | $19M | $19M | $20M |
| EBIT Avg | $17M | $18M | $17M | $18M | $19M | $19M |
| Low | $17M | $18M | $17M | $18M | $19M | $19M |
| High | $17M | $18M | $17M | $18M | $19M | $19M |
| Net Income Avg | $15M | $16M | $14M | $15M | $16M | $17M |
| Low | $15M | $16M | $14M | $15M | $16M | $17M |
| High | $15M | $16M | $14M | $15M | $16M | $17M |
| EPS Avg | $0.89 | $0.96 | $0.86 | $0.93 | $0.98 | $1.02 |
| Low | $0.89 | $0.96 | $0.86 | $0.93 | $0.98 | $1.02 |
| High | $0.89 | $0.96 | $0.87 | $0.93 | $0.98 | $1.02 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |